Description

1. Policy & strategic support National Industrial Development Strategy prioritizes pharmaceuticals Health Sector Transformation Plan (HSTP) supports local drug production Import substitution policy for essential medicines 2. Tax & fiscal incentives Duty-free import of machinery, equipment, and spare parts Customs tax exemption on raw materials for pharmaceutical production Income tax holidays (up to 7–10 years depending on location) 3. Access to industrial parks Kilinto Pharmaceutical Industrial Park (dedicated to pharma) Ready infrastructure: power, water, wastewater treatment Reduced land lease cost 4. Preferential public procurement Government hospitals encouraged to buy locally manufactured medicines Framework contracts through EPSA (EPSS) favor local producers Advance purchase commitments for essential drugs 5. Regulatory & quality support Ethiopian Food and Drug Authority (EFDA) technical guidance Support for GMP compliance Faster registration pathways for locally produced essential medicines 6. Financial & investment support Access to Development Bank of Ethiopia (DBE) loans Incentives for foreign direct investment (FDI) & joint ventures Investment facilitation via Ethiopian Investment Commission (EIC) 7. Skills & capacity building Government-supported training programs University–industry collaboration (pharmacy & chemistry) Support for technology transfer initiatives 8. Export facilitation Export incentives and support programs Regional market access (COMESA, AfCFTA) Support for international certification (WHO PQ) 9. Infrastructure & utilities Priority access to electricity and utilities Stable supply arrangements in industrial parks Centralized waste treatment for pharma compliance 10. Institutional coordination MoH, Ministry of Industry, EFDA, EIC, EPSA working together Public–private partnership (PPP) frameworks